Back to company

GALECTO BIOTECH ApS: Financial statements 2016

CVR: 34878366

GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -1,338,209 and a net result of DKK -1,842,834 compared with DKK -503,972 the year before. Equity amounted to DKK -6,459,739.

Gross Profit
-1,338,209 kr.
Profit/Loss
-1,842,834 kr.
Equity
-6,459,739 kr.
Total Assets
1,992,218 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--1.3 mio.-1.8 mio.-6.5 mio.-
2015-865 t.-504 t.-4.6 mio.-
2014--15 mio.-12 mio.-30.6 mio.-
2013--15 mio.-17.1 mio.-18.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GALECTO BIOTECH ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

GALECTO BIOTECH ApS: The 2015 annual report is outApr 14, 2016

GALECTO BIOTECH ApS has published its annual report for 2015. Gross profit came to DKK 864,833, and the net result was DKK -503,972.

About GALECTO BIOTECH ApS

GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees. In 2024, the company reported a gross profit of DKK 5,477,168 and a net result of DKK 310,297 compared with DKK 849,392 the year before. Equity amounted to DKK 8,553,704.